Dynavax Technologies Corp. (DVAX)
15.38
+0.01
(+0.07%)
USD |
NASDAQ |
Dec 30, 16:00
15.38
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies EPS Diluted (Quarterly): 0.2063 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Agios Pharmaceuticals, Inc. | -1.779 |
| Hyperion DeFi, Inc. | 0.0544 |
| Edgewise Therapeutics, Inc. | -0.3855 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 26.93M |
| Revenue (Quarterly) | 94.88M |
| Total Expenses (Quarterly) | 67.95M |
| Enterprise Value | 1.446B |
| Gross Profit Margin (Quarterly) | 84.82% |
| Profit Margin (Quarterly) | 28.38% |
| Earnings Yield | -2.48% |
| Operating Earnings Yield | 0.49% |
| Normalized Earnings Yield | 0.5091 |